Long answer question (15marks) 1. Write a detail note on urea cycle with reaction? Mention its major metablic disorders . 2. Explain the transamination reaction ? Involved in the catabolism of amino acids. 3. What are the bile pigments. Name the diseases aassociated with their metablism. 4. What are transaminase. Write the fiagnostic importance of transaminases. 5. What are porphyrin. Explain the type and clinical importance of porphyria. Short answer question ( 5 marks) 1. Explain the transamination reaction involved in thr catabolism of amino avids. 2. Explain phenoketoneumia and alkaptoneumia 3. What is porphyria? 4. What is jaundice? Explain the different types of jaundice? 5. What is normal blood urea level? Name two condition in which blood urea level is elevated .

Reading File

Finding Sources

Now let me read key textbook sections in parallel:

Reading File

Now I have enough information to write comprehensive answers. Let me compile them all:

BIOCHEMISTRY EXAMINATION ANSWERS

LONG ANSWER QUESTIONS (15 Marks Each)

1. Urea Cycle — Detailed Note with Reactions & Major Metabolic Disorders

Introduction

The urea cycle (also called the ornithine cycle or Krebs–Henseleit cycle) is the primary pathway for the disposal of excess nitrogen derived from amino acid catabolism. It occurs predominantly in the liver (periportal hepatocytes), though some enzymes are present in the intestine. Urea is the main nitrogenous waste product in humans and is excreted by the kidneys.

Location

Carbamoyl phosphate synthetase I (CPS I) and ornithine transcarbamylase (OTC) — mitochondrial matrix
Remaining three enzymes — cytosol

Overall Reaction

$$2, \text{NH}_3 + \text{CO}_2 + 3, \text{ATP} + 3, \text{H}_2\text{O} \longrightarrow \text{Urea} + 2, \text{ADP} + \text{AMP} + 4, \text{P}_i$$

Steps of the Urea Cycle

Step 1 — Formation of Carbamoyl Phosphate (Mitochondria)

NH₃ + CO₂ + 2 ATP → Carbamoyl phosphate + 2 ADP + Pᵢ Enzyme: Carbamoyl phosphate synthetase I (CPS I) Cofactor: N-acetylglutamate (allosteric activator, essential) This is the rate-limiting step of the cycle.

Step 2 — Formation of Citrulline (Mitochondria)

Carbamoyl phosphate + Ornithine → Citrulline + Pᵢ Enzyme: Ornithine transcarbamylase (OTC) Citrulline is transported from mitochondria to cytosol in exchange for ornithine via the ornithine-citrulline antiporter.

Step 3 — Formation of Argininosuccinate (Cytosol)

Citrulline + Aspartate + ATP → Argininosuccinate + AMP + PPᵢ Enzyme: Argininosuccinate synthetase Note: Aspartate donates the second nitrogen of urea. The energy for this condensation comes from ATP hydrolysis to AMP + PPᵢ (equivalent to 2 high-energy bonds consumed).

Step 4 — Cleavage of Argininosuccinate (Cytosol)

Argininosuccinate → Arginine + Fumarate Enzyme: Argininosuccinase (Argininosuccinate lyase) Fumarate enters the TCA cycle (connects urea cycle to TCA cycle = "bicyclic system").

Step 5 — Hydrolysis of Arginine (Cytosol)

Arginine + H₂O → Urea + Ornithine Enzyme: Arginase Ornithine is transported back into the mitochondria to accept another carbamoyl phosphate — completing the cycle. Urea is released into blood and excreted by kidneys.

Summary Diagram (Textual)

NH₃ + CO₂ → Carbamoyl phosphate → + Ornithine → Citrulline (exits mitochondria)
→ + Aspartate → Argininosuccinate → Arginine + Fumarate
→ Arginine + H₂O → Urea + Ornithine (returns to mitochondria)

Energetics

3 ATP molecules are consumed per urea molecule synthesized (2 in Step 1, 1 in Step 3 as AMP equivalent = 2 high-energy bonds)

Nitrogen Sources

First N: from free NH₃ (via glutamate dehydrogenase/transamination) → carbamoyl phosphate
Second N: from aspartate (derived from transamination of oxaloacetate with glutamate)

Regulation

N-acetylglutamate (NAG) activates CPS I — NAG synthase is stimulated by arginine (feed-forward activation when arginine levels rise)
High-protein diet increases urea cycle enzyme expression

Link with TCA Cycle

Fumarate produced in Step 4 enters the TCA cycle → oxaloacetate → transaminates with glutamate → aspartate (re-enters urea cycle). This interconnection is called the Krebs bicycle.

Major Metabolic Disorders of the Urea Cycle

All are autosomal recessive (except OTC deficiency which is X-linked). All result in hyperammonemia, which is toxic to the brain.

Disorder	Deficient Enzyme	Accumulating Metabolite	Key Features
CPS I deficiency	Carbamoyl phosphate synthetase I	NH₃	Severe neonatal hyperammonemia; no orotic acid in urine
OTC deficiency (most common)	Ornithine transcarbamylase	NH₃, orotic acid↑ in urine	X-linked; carbamoyl phosphate diverted to pyrimidine synthesis → orotic aciduria
Citrullinemia (type I)	Argininosuccinate synthetase	Citrulline	Elevated plasma citrulline; hyperammonemia
Argininosuccinic aciduria	Argininosuccinase	Argininosuccinate	Trichorrhexis nodosa (brittle hair); mental retardation
Argininemia	Arginase	Arginine	Progressive spastic diplegia; less severe hyperammonemia

Clinical Features of Hyperammonemia

Neonatal: vomiting, lethargy, hypotonia, seizures, coma, death
Older children: intellectual disability, ataxia, behavioral disturbances
Amino acid supplementation (arginine/citrulline) and protein restriction are mainstays of treatment; sodium benzoate/phenylbutyrate used to provide alternative nitrogen excretion routes

(Harper's Illustrated Biochemistry, 32nd Ed; Harrison's Principles of Internal Medicine 22E)

2. Transamination Reaction in Catabolism of Amino Acids

Definition

Transamination is a reversible enzymatic reaction in which the α-amino group of an amino acid is transferred to an α-keto acid, producing a new amino acid and the α-keto acid corresponding to the original amino acid.

General Reaction

$$\text{Amino acid}_1 + \alpha\text{-keto acid}_2 \underset{\text{PLP}}{\rightleftharpoons} \alpha\text{-keto acid}_1 + \text{Amino acid}_2$$

Most commonly: $$\text{Amino acid} + \alpha\text{-Ketoglutarate} \underset{\text{Transaminase (PLP)}}{\rightleftharpoons} \alpha\text{-Keto acid} + \text{Glutamate}$$

Coenzyme

Pyridoxal phosphate (PLP) — the active form of Vitamin B₆ — is the essential coenzyme for ALL transaminases (aminotransferases).
PLP serves as a carrier of amino groups: it alternates between pyridoxal phosphate (aldehyde form, accepts amino group → becomes pyridoxamine phosphate) and pyridoxamine phosphate (amine form, donates amino group).
This is called the ping-pong (double-displacement) mechanism.

Mechanism (Ping-Pong)

PLP on the enzyme reacts with the amino acid → Schiff base (aldimine) formed
The Schiff base tautomerizes → ketimine
Hydrolysis of ketimine → α-keto acid released + enzyme-bound pyridoxamine phosphate (PMP)
PMP reacts with the second α-keto acid (usually α-ketoglutarate) → new Schiff base
Hydrolysis → glutamate released + PLP regenerated

Key Transaminases

1. Aspartate Aminotransferase (AST) / Glutamate-Oxaloacetate Transaminase (GOT)

Aspartate + α-Ketoglutarate ⇌ Oxaloacetate + Glutamate

2. Alanine Aminotransferase (ALT) / Glutamate-Pyruvate Transaminase (GPT)

Alanine + α-Ketoglutarate ⇌ Pyruvate + Glutamate

Role in Amino Acid Catabolism

Transamination funnels nitrogen from most amino acids into glutamate
Glutamate then undergoes oxidative deamination by glutamate dehydrogenase:

Glutamate + NAD⁺ → α-Ketoglutarate + NH₃ + NADH
The NH₃ produced feeds into the urea cycle for excretion
The carbon skeleton (α-keto acid) is channeled into energy metabolism (gluconeogenesis, TCA cycle)

Significance

Transamination + oxidative deamination together = major pathway of amino nitrogen disposal
Connects amino acid metabolism to carbohydrate metabolism
Glucose-Alanine cycle: muscle → alanine → liver transamination → pyruvate → glucose (gluconeogenesis)

(Basic Medical Biochemistry – A Clinical Approach, 6e; Harper's Illustrated Biochemistry, 32nd Ed)

3. Bile Pigments — Definition, Metabolism & Associated Diseases

What are Bile Pigments?

Bile pigments are colored breakdown products of the heme portion of hemoglobin (and other heme-containing proteins). The main bile pigments are:

Bilirubin — yellow pigment (predominant)
Biliverdin — green pigment (intermediate)
Urobilinogen — colorless (in intestine/urine)
Urobilin — yellow (urine)
Stercobilinogen / Stercobilin — brown (feces)

Metabolism of Bilirubin (Step by Step)

Phase 1 — Formation (Reticuloendothelial System)

Aged/damaged RBCs → hemoglobin is phagocytosed by macrophages (spleen, liver, bone marrow)
Heme → heme oxygenase → biliverdin + CO + Fe²⁺
Biliverdin → biliverdin reductase (NADPH) → Bilirubin (unconjugated/indirect)
~85% from RBC hemoglobin; ~15% from other heme proteins (myoglobin, cytochromes)
Bilirubin is water-insoluble, lipid-soluble, toxic

Phase 2 — Transport

Unconjugated bilirubin binds tightly to serum albumin (non-covalent) for transport to liver
Cannot be filtered by kidneys (albumin-bound) → not in normal urine

Phase 3 — Hepatic Uptake & Conjugation

In hepatocytes: bilirubin dissociates from albumin
Taken up by carrier proteins (OATP1B1, OATP1B3) → binds intracellular ligandin (Y protein)
UDP-glucuronosyltransferase (UGT1A1) conjugates bilirubin with glucuronic acid
→ Bilirubin diglucuronide (conjugated/direct bilirubin) — water-soluble, non-toxic

Phase 4 — Excretion into Bile

Conjugated bilirubin → excreted into bile via MRP2 (canalicular transporter)
Passes through bile ducts into the duodenum

Phase 5 — Intestinal Transformation

Gut bacteria reduce bilirubin diglucuronide → urobilinogen (colorless)
Most urobilinogen → oxidized to stercobilin (brown color of feces)
~20% urobilinogen reabsorbed (enterohepatic circulation): most re-excreted in bile; small amount → urine as urobilin (yellow)

Normal Serum Bilirubin

Total bilirubin: 0.3–1.0 mg/dL
Direct (conjugated): 0–0.3 mg/dL
Indirect (unconjugated): 0.2–0.7 mg/dL
Jaundice clinically apparent when total bilirubin > 2.5–3 mg/dL

Diseases Associated with Bile Pigment Metabolism

A. Hemolytic (Prehepatic) Jaundice

Excess hemolysis overwhelms liver conjugation capacity
↑ Unconjugated bilirubin; normal/↑ urobilinogen in urine; no bilirubin in urine
Causes: hereditary spherocytosis, G6PD deficiency, sickle cell disease, malaria, transfusion reactions

B. Hepatocellular (Hepatic) Jaundice

Damaged hepatocytes fail to conjugate and/or excrete bilirubin
↑ Both conjugated and unconjugated bilirubin
Bilirubin in urine (bilirubinuria); pale stools; dark urine
Causes: viral hepatitis, alcoholic hepatitis, cirrhosis, drugs

C. Obstructive (Posthepatic/Cholestatic) Jaundice

Bile duct obstruction prevents excretion of conjugated bilirubin
↑ Conjugated bilirubin; absent urobilinogen in urine/feces; pale ("clay-colored") stools; dark urine
Causes: gallstones in CBD, carcinoma of head of pancreas, cholangiocarcinoma, biliary stricture

D. Neonatal Jaundice (Physiological)

Immature UGT1A1 activity in newborns; excess bilirubin load from fetal Hb breakdown
↑ Unconjugated bilirubin; resolves in 1–2 weeks
Kernicterus: bilirubin crosses blood-brain barrier → brain damage

E. Inherited Disorders of Bilirubin Metabolism

Disorder	Defect	Bilirubin type	Severity
Gilbert syndrome	↓ UGT1A1 (~70%)	↑ Unconjugated	Benign; jaundice with fasting/stress
Crigler-Najjar type I	Absent UGT1A1	↑↑ Unconjugated	Fatal without liver transplant
Crigler-Najjar type II	Markedly ↓ UGT1A1	↑ Unconjugated	Managed with phototherapy
Dubin-Johnson syndrome	Defective MRP2 transporter	↑ Conjugated	Benign; black liver
Rotor syndrome	Defective OATP1B1/1B3	↑ Conjugated	Benign

(Tintinalli's Emergency Medicine; Tietz Textbook of Laboratory Medicine, 7th Ed)

4. Transaminases — Definition & Diagnostic Importance

Definition

Transaminases (aminotransferases) are transferase enzymes that catalyze transamination reactions — the transfer of an amino group from an amino acid to an α-keto acid. They require pyridoxal phosphate (PLP, Vitamin B₆) as coenzyme.

Clinically Important Transaminases

1. Aspartate Aminotransferase (AST)

Formerly: GOT (Glutamate-Oxaloacetate Transaminase)
Reaction: Aspartate + α-Ketoglutarate ⇌ Oxaloacetate + Glutamate
Found in: Heart, liver, skeletal muscle, kidney, brain (in decreasing order)
Normal serum: 5–40 IU/L
Both cytoplasmic and mitochondrial isoforms exist

2. Alanine Aminotransferase (ALT)

Formerly: GPT (Glutamate-Pyruvate Transaminase)
Reaction: Alanine + α-Ketoglutarate ⇌ Pyruvate + Glutamate
Found predominantly in: Liver (most liver-specific transaminase)
Normal serum: 5–35 IU/L
Almost exclusively cytoplasmic

Diagnostic Importance

1. Acute Myocardial Infarction (AMI)

AST rises within 6–12 hours, peaks at 24–36 hours, returns to normal in 3–5 days
AST:ALT ratio > 2 (DeRitis ratio) is characteristic
Note: Troponin and CK-MB have largely replaced AST for cardiac diagnosis, but AST was historically the key enzyme for MI diagnosis

2. Liver Disease

Viral hepatitis: ALT and AST both rise dramatically (10–100× normal); ALT > AST (ALT is more liver-specific)
In alcoholic hepatitis: AST:ALT ratio > 2:1 (because alcohol damages mitochondria, releasing mitochondrial AST, and because alcohol impairs PLP availability for ALT synthesis)
Cirrhosis/liver failure: may show normal or mildly elevated enzymes as hepatocyte mass is lost
NAFLD (fatty liver): mild-moderate elevation, ALT > AST

3. AST:ALT (De Ritis) Ratio

Ratio	Interpretation
< 1 (ALT > AST)	Viral hepatitis, NAFLD
> 2 (AST:ALT)	Alcoholic liver disease
> 2 with markedly elevated AST	Cirrhosis

4. Skeletal Muscle Disease

Muscular dystrophies, polymyositis: AST elevated; ALT usually normal
Helps differentiate from liver disease (check CK simultaneously)

5. Other Uses

Obstructive jaundice: transaminases mildly elevated (ALP rises disproportionately more)
Drug-induced hepatotoxicity (paracetamol, isoniazid, statins): elevated ALT
Hemolytic anemia: mild AST rise from RBC lysis
Post-surgery or post-cardiac catheterization: transient rise

6. Monitoring

Serial measurement guides disease progression and treatment response (e.g., antiviral therapy in hepatitis B/C, immunosuppression in autoimmune hepatitis)

Summary Table — Conditions and Transaminase Patterns

Condition	AST	ALT	AST:ALT
Viral hepatitis	↑↑↑	↑↑↑↑	< 1
Alcoholic hepatitis	↑↑	↑	> 2
Myocardial infarction	↑↑	Normal/slight ↑	> 2
Obstructive jaundice	Normal/↑	Normal/↑	Variable
Muscle disease	↑↑	Normal	> 1

(Basic Medical Biochemistry – A Clinical Approach, 6e; Tietz Textbook of Laboratory Medicine, 7th Ed)

5. Porphyrins — Definition, Types & Clinical Importance of Porphyria

Definition of Porphyrins

Porphyrins are cyclic organic molecules composed of four pyrrole rings linked by methine bridges (=CH–). They have the ability to chelate metal ions, most importantly iron in heme. The word "porphyrin" derives from the Greek porphuros (purple), reflecting the purple/red color of oxidized tetrapyrroles.

Structure

Basic unit: Pyrrole ring
Four pyrroles joined by methine bridges = porphine (parent compound)
Substituents on the pyrrole rings give rise to different types (uroporphyrin, coproporphyrin, protoporphyrin)
Heme = Protoporphyrin IX + Fe²⁺

Heme Biosynthesis (Summary — relevant to porphyria)

Glycine + Succinyl CoA → δ-Aminolevulinic acid (ALA) [ALA synthase — rate-limiting; in mitochondria]
2 ALA → Porphobilinogen (PBG) [ALA dehydratase/PBGS]
4 PBG → Hydroxymethylbilane → Uroporphyrinogen III
Uroporphyrinogen III → Coproporphyrinogen III → Protoporphyrinogen IX → Protoporphyrin IX
Protoporphyrin IX + Fe²⁺ → Heme [Ferrochelatase; in mitochondria]

Each enzyme deficiency → specific porphyria with characteristic accumulation of precursors.

The Porphyrias — Definition

Porphyrias are a group of rare, mainly inherited metabolic disorders resulting from partial enzyme deficiencies (or in one case, increased activity) in the heme biosynthesis pathway. Each type is defined by a characteristic clinical presentation and a specific pattern of heme precursor accumulation.

(Tietz Textbook of Laboratory Medicine, 7th Ed)

Classification

A. By Site of Enzyme Defect:

Hepatic porphyrias — enzyme deficiency predominantly in liver
Erythropoietic porphyrias — enzyme deficiency predominantly in bone marrow

B. By Clinical Presentation (most important classification):

Acute (Neurovisceral) Porphyrias
Non-acute (Cutaneous) Porphyrias

Types of Porphyria

Type	Deficient Enzyme	Inheritance	Category	Key Features
AIP (Acute Intermittent Porphyria)	PBG deaminase (HMB synthase)	AD	Acute hepatic	Most common acute porphyria; NO skin lesions; neurovisceral attacks
ADP (ALA Dehydratase Deficiency Porphyria)	ALA dehydratase (PBGS)	AR	Acute hepatic	Rarest; similar to AIP
VP (Variegate Porphyria)	Protoporphyrinogen oxidase	AD	Acute + cutaneous	Skin + neurovisceral attacks
HCP (Hereditary Coproporphyria)	Coproporphyrinogen oxidase	AD	Acute + cutaneous	Skin + neurovisceral attacks
PCT (Porphyria Cutanea Tarda)	Uroporphyrinogen decarboxylase	AD/sporadic	Non-acute cutaneous	Most common porphyria overall; blistering on sun-exposed skin
CEP (Congenital Erythropoietic Porphyria)	Uroporphyrinogen III synthase	AR	Erythropoietic cutaneous	Severe photosensitivity; red urine; hemolytic anemia
EPP (Erythropoietic Protoporphyria)	Ferrochelatase (↓)	AD	Erythropoietic cutaneous	Burning pain on sun exposure; no blisters
XLEPP (X-linked EPP)	ALA synthase 2 (↑ gain of function)	X-linked	Erythropoietic	Similar to EPP

Clinical Features

Acute Attacks (AIP, VP, HCP):

Severe abdominal pain (colicky) — most common symptom
Nausea, vomiting, constipation
Peripheral neuropathy (motor > sensory)
Psychiatric symptoms: anxiety, depression, psychosis
Autonomic dysfunction: tachycardia, hypertension, sweating
Hyponatremia (SIADH)
Precipitants: drugs (barbiturates, sulfonamides, rifampicin, OCP), fasting, alcohol, infections, hormonal changes
Urine: dark reddish/port-wine color (PBG oxidizes to porphobilin on standing)

Cutaneous Features (PCT, CEP, EPP):

Photosensitivity — due to porphyrin accumulation in skin → excitation by UV light → reactive oxygen species → tissue damage
Bullae, vesicles, skin fragility on sun-exposed areas
Hypertrichosis, hyperpigmentation (PCT)

Diagnosis

Urine: ↑ ALA + PBG (in acute porphyrias); ↑ uroporphyrin (PCT, CEP)
Feces: ↑ protoporphyrin (VP, EPP); ↑ coproporphyrin (HCP)
Blood: ↑ erythrocyte protoporphyrin (EPP)
Watson-Schwartz test / Hoesch test: screening for urinary PBG (turns pink/red with Ehrlich's reagent)
Gold standard: enzyme assays + DNA mutation analysis

Treatment

Acute attacks: IV glucose (high carbohydrate loading suppresses ALA synthase), IV hematin/heme arginate
Avoid precipitating drugs
PCT: phlebotomy, hydroxychloroquine; avoid alcohol, iron, estrogens
EPP: beta-carotene (sunscreen effect), afamelanotide

(Tietz Textbook of Laboratory Medicine, 7th Ed; Emery's Elements of Medical Genetics and Genomics)

SHORT ANSWER QUESTIONS (5 Marks Each)

1. Transamination Reaction in Catabolism of Amino Acids

Transamination is the reversible transfer of an α-amino group from an amino acid to an α-keto acid, catalyzed by aminotransferases (transaminases) using pyridoxal phosphate (PLP) as coenzyme.

General Reaction:

Amino acid + α-Ketoglutarate ⇌ α-Keto acid + Glutamate

Examples:

AST (GOT): Aspartate + α-Ketoglutarate ⇌ Oxaloacetate + Glutamate
ALT (GPT): Alanine + α-Ketoglutarate ⇌ Pyruvate + Glutamate

Mechanism: Ping-pong (double-displacement): PLP alternates between pyridoxal phosphate (aldehyde form) and pyridoxamine phosphate (amine form).

Role in catabolism: All amino acids (except lysine and threonine) undergo transamination. The amino group is funneled into glutamate, which is then oxidatively deaminated by glutamate dehydrogenase to release free NH₃ → enters the urea cycle for excretion. The resulting α-keto acids enter metabolic pathways (gluconeogenesis/TCA cycle). Transamination thus serves as the central gateway for amino acid nitrogen disposal.

2. Phenylketonuria (PKU) and Alkaptonuria

Phenylketonuria (PKU)

Deficient enzyme: Phenylalanine hydroxylase (PAH) — or rarely, dihydrobiopterin reductase
Metabolic defect: Phenylalanine cannot be converted to tyrosine → phenylalanine accumulates → diverted to phenylpyruvate, phenyllactate, phenylacetate (phenylketones)
Inheritance: Autosomal recessive
Clinical features:
- Normal at birth (placenta clears excess phenylalanine)
- Progressive intellectual disability if untreated
- Seizures, microcephaly
- Fair skin, blonde hair, blue eyes (reduced melanin — tyrosine needed for melanin)
- Musty/mousy odor of urine and sweat (phenylacetic acid)
- Eczema
Diagnosis: Neonatal screening (Guthrie test / tandem mass spectrometry); elevated blood phenylalanine (> 20 mg/dL)
Treatment: Phenylalanine-restricted diet (low-phenylalanine formula); sapropterin (BH4 analog) for responsive cases; pegvaliase enzyme therapy

(Basic Medical Biochemistry – A Clinical Approach, 6e; Lippincott Illustrated Reviews: Biochemistry)

Alkaptonuria

Deficient enzyme: Homogentisate oxidase (homogentisate 1,2-dioxygenase)
Metabolic defect: Tyrosine catabolism is blocked at homogentisate → homogentisic acid accumulates
Inheritance: Autosomal recessive
Clinical features:
- Dark urine on standing or exposure to air (homogentisic acid oxidizes → dark brown/black pigment)
- Ochronosis: black-brown pigment deposits in connective tissues (cartilage, tendons, sclera, ear cartilage) → joint damage
- Arthritis (ochronotic arthropathy) — presents in 4th–5th decade
- Darkening of diaper/urine in infants
Diagnosis: Urine: reduces Fehling's/Benedict's solution; HPLC shows elevated homogentisic acid
Treatment: Nitisinone (NTBC) — inhibits upstream enzyme (4-hydroxyphenylpyruvate dioxygenase) reducing homogentisate production; high-dose Vitamin C; low-protein diet

(Basic Medical Biochemistry – A Clinical Approach, 6e)

3. Porphyria

Porphyria refers to a group of rare, mainly inherited metabolic disorders caused by partial enzyme deficiencies in the heme biosynthesis pathway. Each type results in the accumulation of specific heme precursors (porphyrins or their precursors ALA/PBG) upstream of the deficient enzyme, with characteristic clinical manifestations.

Two main clinical forms:

Acute (neurovisceral) porphyrias (e.g., AIP, VP, HCP): characterized by attacks of severe abdominal pain, nausea, autonomic neuropathy, psychiatric symptoms, and motor neuropathy; precipitated by certain drugs, fasting, alcohol, and hormones. Urine turns dark/port-wine colored.
Cutaneous (non-acute) porphyrias (e.g., PCT, EPP, CEP): characterized by photosensitivity, skin blistering/bullae on sun-exposed areas due to porphyrin accumulation in skin.

Key diagnostic test: Watson-Schwartz test (urinary PBG with Ehrlich's reagent — pink/red in acute porphyrias).

Treatment: Acute attacks — IV glucose loading + IV hematin/heme arginate; avoid precipitating drugs.

(Tietz Textbook of Laboratory Medicine, 7th Ed)

4. Jaundice — Definition and Types

Definition

Jaundice (icterus) is a clinical condition characterized by yellow discoloration of skin, sclera, and mucous membranes due to hyperbilirubinemia (elevated serum bilirubin > 2.5–3 mg/dL). Bile pigment (bilirubin) deposits in tissues cause the yellow coloration.

(Tietz Textbook of Laboratory Medicine; Tintinalli's Emergency Medicine)

Types of Jaundice

Type 1: Pre-hepatic (Hemolytic) Jaundice

Cause: Excessive destruction (hemolysis) of RBCs → excess bilirubin production overwhelms liver's conjugation capacity
Bilirubin: ↑↑ Unconjugated (indirect) bilirubin
Urine bilirubin: Absent (unconjugated bilirubin is albumin-bound, cannot be filtered)
Urobilinogen in urine: Markedly increased
Stool color: Dark (excess stercobilin)
Causes: Hemolytic anemia (G6PD deficiency, hereditary spherocytosis, sickle cell), incompatible blood transfusion, malaria
Liver enzymes: Normal

Type 2: Hepatic (Hepatocellular) Jaundice

Cause: Damaged hepatocytes cannot adequately take up, conjugate, or excrete bilirubin
Bilirubin: ↑ Both conjugated AND unconjugated bilirubin
Urine bilirubin: Present (bilirubinuria → dark urine)
Urobilinogen in urine: Variable (↑ in early hepatitis due to shunting; ↓ in severe damage)
Stool color: Pale to normal
Causes: Viral hepatitis (A, B, C), alcoholic hepatitis, liver cirrhosis, drug-induced hepatitis (paracetamol, isoniazid), autoimmune hepatitis
Liver enzymes (ALT/AST): Markedly elevated

Type 3: Post-hepatic (Obstructive/Cholestatic) Jaundice

Cause: Obstruction of bile ducts → conjugated bilirubin cannot be excreted into intestine → regurgitates into blood
Bilirubin: ↑↑ Conjugated (direct) bilirubin
Urine bilirubin: Present (dark "tea-colored" urine)
Urobilinogen in urine: Absent (no bilirubin reaching intestine)
Stool color: Pale, clay-colored (acholic stools) — no stercobilin
Causes: Gallstones in common bile duct (choledocholithiasis), carcinoma of head of pancreas, cholangiocarcinoma, biliary stricture, primary sclerosing cholangitis
Liver enzymes: ALP markedly elevated; transaminases mildly elevated

Type 4: Neonatal (Physiological) Jaundice

Cause: Immature hepatic UDP-glucuronosyltransferase (UGT1A1); increased RBC turnover (fetal Hb replacement)
Bilirubin: ↑ Unconjugated
Appears on Day 2–3, resolves by Day 7–10 (term) or Day 14 (preterm)
Risk: Kernicterus (bilirubin encephalopathy) if unconjugated bilirubin > 20 mg/dL
Treatment: Phototherapy; exchange transfusion in severe cases

Comparison Table

Feature	Pre-hepatic	Hepatic	Post-hepatic
Serum bilirubin	Unconjugated ↑	Both ↑	Conjugated ↑
Urine bilirubin	Absent	Present	Present
Urine urobilinogen	↑↑↑	Variable	Absent
Stool color	Dark	Pale-normal	Clay/pale
ALT/AST	Normal	↑↑↑	Normal/↑
ALP	Normal	↑	↑↑↑
Pruritus	Absent	Absent/mild	Present

(Tintinalli's Emergency Medicine; Tietz Textbook of Laboratory Medicine, 7th Ed)

5. Normal Blood Urea Level & Conditions with Elevated Blood Urea

Normal Blood Urea Level

Blood urea (BUN — Blood Urea Nitrogen): 8–20 mg/dL (2.9–7.1 mmol/L)
Blood urea (as total urea): 15–40 mg/dL (some sources: 20–40 mg/dL)
Serum urea: approximately 2.5 × BUN (since urea is 28/60 nitrogen)
Urea is freely filtered by glomeruli and partially reabsorbed in tubules

Elevated Blood Urea = Azotemia / Uremia

Condition 1: Renal Failure (Pre-renal, Renal, Post-renal)

The most common cause. Reduced glomerular filtration rate (GFR) → urea accumulates in blood.
Pre-renal (↓ renal blood flow): dehydration, cardiac failure, shock, hemorrhage
Intrinsic renal failure: acute tubular necrosis (ATN), glomerulonephritis, chronic kidney disease (CKD)
Post-renal (obstructive): ureteric stones, prostatic hypertrophy, bladder tumor
BUN:Creatinine ratio: > 20:1 suggests pre-renal; 10–20:1 suggests renal

Condition 2: High Protein Intake / Increased Protein Catabolism

High dietary protein → more amino acid catabolism → more NH₃ → more urea synthesis
Also elevated in: GI bleeding (protein load from digested blood in intestine), severe catabolic states (major surgery, burns, infections, corticosteroid therapy), starvation (muscle breakdown)

Other Causes of Elevated Blood Urea:

Dehydration (hemoconcentration)
Fever, prolonged exercise
Diabetes mellitus with osmotic diuresis
Certain drugs (tetracyclines, corticosteroids)

Decreased Blood Urea (Hypoazotemia):

Severe liver disease (impaired urea synthesis)
Malnutrition / very low protein diet
Pregnancy (dilution effect)

(Tietz Textbook of Laboratory Medicine, 7th Ed; Harrison's Principles of Internal Medicine 22E)

Sources: Harper's Illustrated Biochemistry (32nd Ed) | Basic Medical Biochemistry – A Clinical Approach (6th Ed) | Lippincott Illustrated Reviews: Biochemistry (8th Ed) | Tietz Textbook of Laboratory Medicine (7th Ed) | Harrison's Principles of Internal Medicine (22nd Ed) | Tintinalli's Emergency Medicine | Emery's Elements of Medical Genetics and GenomicsAll 10 questions have been answered comprehensively. Here's a quick index of what was covered:

Quick Index

Long Answer Questions (15 Marks)

#	Topic	Key Content
1	Urea Cycle	All 5 steps with enzymes/reactions, energetics, nitrogen sources, regulation, link to TCA cycle, 5 major metabolic disorders (OTC deficiency, CPS I, citrullinemia, argininosuccinic aciduria, argininemia)
2	Transamination	General reaction, PLP coenzyme, ping-pong mechanism, AST/ALT reactions, role in NH₃ disposal and carbon skeleton metabolism
3	Bile Pigments	Full 5-phase metabolism, normal bilirubin values, all 3 types of jaundice + 5 inherited disorders (Gilbert, Crigler-Najjar I&II, Dubin-Johnson, Rotor)
4	Transaminases	AST vs ALT, De Ritis ratio, diagnostic significance in AMI, hepatitis, alcoholic liver disease, muscle disease
5	Porphyrins/Porphyria	Heme biosynthesis, 8 types of porphyria (acute vs cutaneous), clinical features, diagnosis, treatment

Short Answer Questions (5 Marks)

#	Topic
1	Transamination — focused summary
2	PKU (enzyme, features, treatment) + Alkaptonuria (ochronosis, homogentisate)
3	Porphyria — concise definition and key types
4	Jaundice — all 4 types with comparison table
5	Normal BUN (8–20 mg/dL); elevated in renal failure and high protein catabolism/GI bleeding

This is a shared conversation. Sign in to Orris to start your own chat.